SPX5,638.94+117.42 2.13%
DIA415.36+6.58 1.61%
IXIC17,754.09+451.07 2.61%

Citigroup Maintains Neutral on Hologic, Lowers Price Target to $70

Benzinga·03/04/2025 17:32:11
Listen to the news
Citigroup analyst Patrick Donnelly maintains Hologic (NASDAQ:HOLX) with a Neutral and lowers the price target from $80 to $70.